MORIERI, MARIO LUCA

MORIERI, MARIO LUCA  

Dipartimento di Medicina - DIMED  

Mostra records
Risultati 1 - 20 di 100 (tempo di esecuzione: 0.04 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Estimated Oral Semaglutide Exposure Has Distinct Relationships With Glycaemic Response, Weight Loss and Gastrointestinal Tolerability 2026 Fadini G. P.Morieri M. L.Boscaro C.Bonora B. M.Cignarella A. DIABETES, OBESITY AND METABOLISM - -
Integrated left ventricular multi-omics landscape of human cardiometabolic HFpEF 2026 Federico CaponeMario Luca Morieri + CARDIOVASCULAR RESEARCH - -
Joslin Kidney Panel of Circulating Proteins 2026 Morieri M. L. + CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY - -
The importance of treatment sequencing with SGLT2 inhibitors and GLP-1 receptor agonists combination for kidney function preservation in type 2 diabetes 2026 Morieri, Mario LucaBonora, Benedetta MariaFioretto, PaolaFadini, Gian Paolo + DIABETES, OBESITY AND METABOLISM - -
Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease 2025 Morieri M. L. + JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY - -
Early weight loss, diabetes remission and long-term trajectory after diagnosis of type 2 diabetes: a retrospective study 2025 Morieri M. L.Sartore G.Avogaro A.Fadini G. P. + DIABETOLOGIA - -
Long-term effects of adding an SGLT-2 inhibitor to insulin therapy in patients with type 1 diabetes. An observational study and systematic review of real-world evidence 2025 Maran A.Vedovato M.Bonora B. M.Morieri M. L.Fadini G. P. + JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION - -
Long-term preservation of kidney function with SGLT-2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney disease 2025 Fadini G. P.Longato E.Morieri M. L.Antonini M.Avogaro A. + DIABETES, OBESITY AND METABOLISM - -
Stratifying cardiovascular benefits from GLP-1RA: a multisource analysis of patient-level CVOT and real-world data using AI-driven methods 2025 Morieri M. L.Longato E.Sciannameo V.Avogaro A.Fadini G. P. + CARDIOVASCULAR DIABETOLOGY - -
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care 2024 Fadini, Gian PaoloLongato, EnricoMorieri, Mario LucaRigato, MauroAvogaro, Angelo + DIABETOLOGIA - -
Effective interventions in preventing gestational diabetes mellitus: A systematic review and meta-analysis 2024 Morieri M. L. + COMMUNICATIONS MEDICINE - -
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes 2024 Morieri M. L.Avogaro A. + ACTA DIABETOLOGICA - -
Impact of MASLD and MetALD on clinical outcomes: A meta-analysis of preliminary evidence 2024 Morieri M. L. + LIVER INTERNATIONAL - -
Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review 2024 Morieri M. L. + COMMUNICATIONS MEDICINE - -
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk 2024 Fadini G. P.Longato E.Morieri M. L.Avogaro A.Gatti A. + THE LANCET REGIONAL HEALTH. EUROPE - -
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus 2024 Morieri, Mario Lucade Kreutzenberg, Saula Vigili + DIABETES & METABOLISM - -
Precision prognostics for cardiovascular disease in Type 2 diabetes: a systematic review and meta-analysis 2024 Morieri M. L. + COMMUNICATIONS MEDICINE - -
Precision stratification of prognostic risk factors associated with outcomes in gestational diabetes mellitus: a systematic review 2024 Morieri M. L. + COMMUNICATIONS MEDICINE - -
Prevalence and risk factors of glomerular hyperfiltration in adults with type 2 diabetes: A population-based study 2024 Fadini, Gian PaoloMorieri, Mario Luca + DIABETES/METABOLISM RESEARCH AND REVIEWS - -
Reporting guidelines for precision medicine research of clinical relevance: the BePRECISE checklist 2024 Morieri M. L. + NATURE MEDICINE - -